Recommendations on management of gynecological malignancies during the COVID-19 pandemic: perspectives from Chinese gynecological oncologists

Yingmei Wang¹, Shiqian Zhang², Lihui Wei³, Zhongqiu Lin⁴, Xinyu Wang⁵, Jianliu Wang³, Keqin Hua⁶, Manhua Cui⁷, Jiandong Wang⁸, Shixuan Wang⁹, Wen Di¹⁰, Yudong Wang¹¹, Ruifang An¹², Mingrong Xi¹³, Ruixia Guo¹⁴, Qi Zhou¹⁵, Xing Xie⁵, Fengxia Xue¹⁶

Affiliations

¹ Department of Obstetrics and Gynecology, Tianjin Medical University General Hospital, Tianjin, China.
² Department of Gynecology, Qilu Hospital of Shandong University, Jinan, China.
³ Department of Obstetrics and Gynecology, Peking University People's Hospital, Beijing, China.
⁴ Department of Gynecological Oncology, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, China.
⁵ Department of Gynecologic Oncology, Women's Hospital, Zhejiang University School of Medicine, Hangzhou, China.
⁶ Department of Obstetrics and Gynecology, The Obstetrics & Gynecology Hospital of Fudan University, Shanghai, China.
⁷ Department of Obstetrics and Gynecology, The Second Hospital of Jilin University, Changchun, China.
⁸ Department of Gynecologic Oncology, Beijing Obstetrics and Gynecology Hospital, Capital Medical University, Beijing, China.
⁹ Department of Obstetrics and Gynecology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
¹⁰ Department of Obstetrics and Gynecology, Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
¹¹ Department of Obstetrics and Gynecology, International Peace Maternity and Child Health Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
¹² Department of Obstetrics and Gynecology, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China.
¹³ Department of Obstetrics and Gynecology, West China Second Hospital, Sichuan University, Chengdu, China.
¹⁴ Department of Gynecology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
¹⁵ Department of Gynecologic Oncology, Chongqing University Cancer Hospital & Chongqing Cancer Institute & Chongqing Cancer Hospital, Chongqing, China.
¹⁶ Department of Obstetrics and Gynecology, Tianjin Medical University General Hospital, Tianjin, China. xuefengxia@tmu.edu.cn.

PMID: 32458596
PMCID: PMC7286750
DOI: 10.3802/jgo.2020.31.e68

Review

Recommendations on management of gynecological malignancies during the COVID-19 pandemic: perspectives from Chinese gynecological oncologists

Yingmei Wang et al. J Gynecol Oncol. 2020 Jul.

. 2020 Jul;31(4):e68.

doi: 10.3802/jgo.2020.31.e68. Epub 2020 May 27.

Authors

Affiliations

¹ Department of Obstetrics and Gynecology, Tianjin Medical University General Hospital, Tianjin, China.
² Department of Gynecology, Qilu Hospital of Shandong University, Jinan, China.
³ Department of Obstetrics and Gynecology, Peking University People's Hospital, Beijing, China.
⁴ Department of Gynecological Oncology, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, China.
⁵ Department of Gynecologic Oncology, Women's Hospital, Zhejiang University School of Medicine, Hangzhou, China.
⁶ Department of Obstetrics and Gynecology, The Obstetrics & Gynecology Hospital of Fudan University, Shanghai, China.
⁷ Department of Obstetrics and Gynecology, The Second Hospital of Jilin University, Changchun, China.
⁸ Department of Gynecologic Oncology, Beijing Obstetrics and Gynecology Hospital, Capital Medical University, Beijing, China.
⁹ Department of Obstetrics and Gynecology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
¹⁰ Department of Obstetrics and Gynecology, Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
¹¹ Department of Obstetrics and Gynecology, International Peace Maternity and Child Health Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
¹² Department of Obstetrics and Gynecology, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China.
¹³ Department of Obstetrics and Gynecology, West China Second Hospital, Sichuan University, Chengdu, China.
¹⁴ Department of Gynecology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
¹⁵ Department of Gynecologic Oncology, Chongqing University Cancer Hospital & Chongqing Cancer Institute & Chongqing Cancer Hospital, Chongqing, China.
¹⁶ Department of Obstetrics and Gynecology, Tianjin Medical University General Hospital, Tianjin, China. xuefengxia@tmu.edu.cn.

PMID: 32458596
PMCID: PMC7286750
DOI: 10.3802/jgo.2020.31.e68

Abstract

The outbreak of coronavirus disease 2019 (COVID-19) caused by the severe acute respiratory syndrome coronavirus 2 has rapidly spread globally. Cancer patients are at a higher risk of being infected with the coronavirus and are more likely to develop severe complications, as compared to the general population. The increasing spread of COVID-19 presents challenges for the clinical care of patients with gynecological malignancies. Concerted efforts should be put into managing gynecological malignancies in an orderly manner by strictly implementing the measures that are specifically developed for controlling the spread of COVID-19. We have drafted Recommendations on Management of Gynecological Malignancies during the COVID-19 Pandemic based on our experience on controlling COVID-19 pandemic in China. We recommend that patients with gynecological malignancies should be managed in hierarchical and individualized manners in combination with local conditions related to COVID-19. Medical care decision should be balanced between controlling COVID-19 pandemic spread and timely diagnosis and treatment for gynecologic oncology patients.

Keywords: COVID-19; Gynecological Malignancies; Management; Pandemic; Recommendations.

PubMed Disclaimer

Conflict of interest statement

No potential conflict of interest relevant to this article was reported.

Cited by

Impact of the COVID-19 Pandemic on Tumor Stage and Pathohistological Parameters of Vulvar Cancer.
Klamminger GG, Bitterlich A, Nigdelis MP, Schnöder L, Hamoud BH, Solomayer EF, Wagner M. Klamminger GG, et al. J Clin Med. 2024 Jul 11;13(14):4058. doi: 10.3390/jcm13144058. J Clin Med. 2024. PMID: 39064099 Free PMC article.
Challenges and opportunities for ovarian cancer management in the epidemic of Covid-19: lessons learned from Wuhan, China.
Chen Z, Zhang C, Yin J, Xin X, Li H, Wang Y, Tsang BK, Zhang Q. Chen Z, et al. J Ovarian Res. 2021 Feb 18;14(1):35. doi: 10.1186/s13048-021-00784-2. J Ovarian Res. 2021. PMID: 33602258 Free PMC article. Review.
Impact of COVID-19 in gynecologic oncology: a Nationwide Italian Survey of the SIGO and MITO groups.
Bogani G, Apolone G, Ditto A, Scambia G, Panici PB, Angioli R, Pignata S, Greggi S, Scollo P, Delia M, Franchi M, Martinelli F, Signorelli M, Lopez S, Di Donato V, Valabrega G, Ferrandina G, Palaia I, Bergamini A, Bocciolone L, Savarese A, Ghezzi F, Casarin J, Pinelli C, Trojano V, Chiantera V, Giorda G, Sopracordevole F, Malzoni M, Salerno G, Sartori E, Testa A, Zannoni G, Zullo F, Vizza E, Trojano G, Chiantera A, Raspagliesi F. Bogani G, et al. J Gynecol Oncol. 2020 Nov;31(6):e92. doi: 10.3802/jgo.2020.31.e92. J Gynecol Oncol. 2020. PMID: 33078597 Free PMC article.
Practical Recommendations for the Preoperative Screening and Protective Protocols in Cancer Surgeries During COVID-19: A Systematic Review.
Dorri S, Sari F, Seyedhasani SN, Atashi A, Hashemi E, Olfatbakhsh A. Dorri S, et al. Front Surg. 2021 Nov 23;8:678700. doi: 10.3389/fsurg.2021.678700. eCollection 2021. Front Surg. 2021. PMID: 34901132 Free PMC article.
Undergoing active treatment for gynecologic cancer during COVID-19: A qualitative study of the impact on healthcare and social support.
K Moran H, Brooks JV, Spoozak L. K Moran H, et al. Gynecol Oncol Rep. 2020 Nov;34:100659. doi: 10.1016/j.gore.2020.100659. Epub 2020 Oct 21. Gynecol Oncol Rep. 2020. PMID: 33106774 Free PMC article. Review.

See all "Cited by" articles

References

1. Coronaviridae Study Group of the International Committee on Taxonomy of Viruses. The species severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2. Nat Microbiol. 2020;5:536–544. - PMC - PubMed
1. Chang L, Yan Y, Wang L. Coronavirus disease 2019: coronaviruses and blood safety. Transfus Med Rev. 2020;34:75–80. - PMC - PubMed
1. Al-Shamsi HO, Alhazzani W, Alhuraiji A, Coomes EA, Chemaly RF, Almuhanna M, et al. A practical approach to the management of cancer patients during the novel coronavirus disease 2019 (COVID-19) pandemic: an international collaborative group. Oncologist. 2020 Forthcoming. - PMC - PubMed
1. Del Rio C, Malani PN. COVID-19-new insights on a rapidly changing epidemic. JAMA. 2020;323:1339–1340. - PubMed
1. Chen Y, Chen L, Deng Q, Zhang G, Wu K, Ni L, et al. The presence of SARS-CoV-2 RNA in the feces of COVID-19 patients. J Med Virol. 2020 Forthcoming. - PubMed

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Recommendations on management of gynecological malignancies during the COVID-19 pandemic: perspectives from Chinese gynecological oncologists

Affiliations

Recommendations on management of gynecological malignancies during the COVID-19 pandemic: perspectives from Chinese gynecological oncologists

Authors

Affiliations

Abstract

Conflict of interest statement

Similar articles

Cited by

References

Publication types

MeSH terms

LinkOut - more resources

Full Text Sources